Please assess the completion status of the following clinical trial:

Trial Title: Eletriptan Pharmacokinetics In Korean Males

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* healthy male subjects, 18-55 years old~* Body Mass Index (BMI) of 17.5 to 30.5 kg/m2~* provide informed consent~Exclusion Criteria:~* blood pressure \>140/90 mm Hg~* any condition possibly affecting drug absorption~* positive urine drug screen

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Treatment A (Type: EXPERIMENTAL): 1 X 20 mg eletriptan
- Treatment B (Type: EXPERIMENTAL): 1 X 40 mg eletriptan
- Treatment C (Type: EXPERIMENTAL): 2 X 40 mg eletriptan
- Treatment D (Type: EXPERIMENTAL): 1 X 40 mg tablet given 2 hr after initial 1 X 40 mg tablet dose

Based on this trial design, predict the completion outcome and termination type (if applicable).